Insider Transactions Reported by 7 Insiders of Arch Therapeutics, Inc.

Location
Framingham, MA

There are no Buy or Sell transactions made by insiders since 04 Mar 2025

Arch Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JAMES R. SULAT Director 27 Sep 2021
Terrence Norchi PRESIDENT AND CHIEF EXECUTIVE, Director 31 Aug 2023
Dan Yrigoyen Vice President, Sales 10 Nov 2022
Laurence Hicks Director 31 Aug 2023
Guy L. Fish Director 10 Nov 2022
PUNIT DHILLON Director 10 Nov 2022
Michael Abrams Chief Financial Officer 31 Aug 2023

Recent Insider Transactions by Companies or Individuals for Arch Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.